Related references
Note: Only part of the references are listed.Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes
Marinka Kartalija et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Miguel-Angel Martinez-Garcia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Primary ciliary dyskinesia, an orphan disease
Mieke Boon et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Risks associated with the therapeutic use of fluoroquinolones
Ralf Stahlmann et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BLESS Randomized Controlled Trial
David J. Serisier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial
Josje Altenburg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Expert Opinion Why is MRI Still an Under-utilized Modality for Evaluating Thoracic Disorders?
Phillip M. Boiselle et al.
JOURNAL OF THORACIC IMAGING (2013)
Underlying Host Risk Factors for Nontuberculous Mycobacterial Lung Disease
Edward D. Chan et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
David J. Serisier et al.
THORAX (2013)
Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis
Antonello Nicolini et al.
BMC PULMONARY MEDICINE (2013)
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non-Cystic Fibrosis Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Thoracoscopic Lobectomy and Segmentectomy for Infectious Lung Disease
John D. Mitchell et al.
ANNALS OF THORACIC SURGERY (2012)
Bronchiectasis in a Diverse US Population Effects of Ethnicity on Etiology and Sputum Culture
Pamela J. McShane et al.
CHEST (2012)
Clinical Efficacy and Safety of Budesonide-Formoterol in Non-Cystic Fibrosis Bronchiectasis
Miguel Angel Martinez-Garcia et al.
CHEST (2012)
Trends in Bronchiectasis Among Medicare Beneficiaries in the United States, 2000 to 2007
Amy E. Seitz et al.
CHEST (2012)
Pathogenesis of Bronchiectasis
Bart C. Moulton et al.
CLINICS IN CHEST MEDICINE (2012)
The Use of Antiinflammatory Therapy and Macrolides in Bronchiectasis
Charles Feldman
CLINICS IN CHEST MEDICINE (2012)
Bronchiectasis and Nontuberculous Mycobacterial Disease
David E. Griffith et al.
CLINICS IN CHEST MEDICINE (2012)
Nitric oxide in primary ciliary dyskinesia
Woolf T. Walker et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Conroy Wong et al.
LANCET (2012)
The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis
Caroline H. H. Nicolson et al.
RESPIRATORY MEDICINE (2012)
Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis
Laura White et al.
RESPIRATORY MEDICINE (2012)
Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients
Pieter Christian Goeminne et al.
RESPIRATORY RESEARCH (2012)
A Randomized Controlled Trial of Nebulized Gentamicin in Non-Cystic Fibrosis Bronchiectasis
Maeve P. Murray et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Nebulized Hypertonic Saline Decreases IL-8 in Sputum of Patients with Cystic Fibrosis
Emer P. Reeves et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Video-Assisted Thoracic Surgery for Bronchiectasis
Peng Zhang et al.
ANNALS OF THORACIC SURGERY (2011)
Immunomodulatory Effects of Macrolide Antibiotics - Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide Therapy
J. Altenburg et al.
RESPIRATION (2011)
Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study
H. K. Ong et al.
CHRONIC RESPIRATORY DISEASE (2011)
Cystic Fibrosis Transmembrane Conductance Regulator Channel Dysfunction in Non-Cystic Fibrosis Bronchiectasis
Thierry Bienvenu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Trends and Burden of Bronchiectasis-Associated Hospitalizations in the United States, 1993-2006
Amy E. Seitz et al.
CHEST (2010)
Sputum Candida albicans Presages FEV1 Decline and Hospital-Treated Exacerbations in Cystic Fibrosis
Sanjay H. Chotirmall et al.
CHEST (2010)
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Soichiro Kanoh et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Impact of human activities on the ecology of nontuberculous mycobacteria
Joseph O. Falkinham
FUTURE MICROBIOLOGY (2010)
Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa
R. Dhar et al.
THORAX (2010)
British Thoracic Society guideline for non-CF bronchiectasis
M. C. Pasteur et al.
THORAX (2010)
Evolving concepts in biofilm infections
Luanne Hall-Stoodley et al.
CELLULAR MICROBIOLOGY (2009)
Assessing response to treatment of exacerbations of bronchiectasis in adults
M. P. Murray et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis
M. P. Murray et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
M. R. Loebinger et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Assessment of Chest High-Field Magnetic Resonance Imaging in Children and Young Adults With Noncystic Fibrosis Chronic Lung Disease Comparison to High-Resolution Computed Tomography and Correlation With Pulmonary Function
Silvia Montella et al.
INVESTIGATIVE RADIOLOGY (2009)
Quorum sensing and social networking in the microbial world
Steve Atkinson et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2009)
Molecular Aspects of Moraxella catarrhalis Pathogenesis
Stefan P. W. de Vries et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2009)
Pulmonary Nontuberculous Mycobacterial Disease Prospective Study of a Distinct Preexisting Syndrome
Richard D. Kim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
Philip M. Farrell et al.
JOURNAL OF PEDIATRICS (2008)
Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis
G. A. Anwar et al.
RESPIRATORY MEDICINE (2008)
Exacerbations in cystic fibrosis: 4. Non-cystic fibrosis bronchiectasis
A. B. Chang et al.
THORAX (2008)
Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis
Miguel Angel Martinez-Garcia et al.
CHEST (2007)
Microbiologic follow-up study in adult bronchiectasis
Paul T. King et al.
RESPIRATORY MEDICINE (2007)
Analysis of the factors related to mortality in patients with bronchiectasis
Zeynep Pinar Onen et al.
RESPIRATORY MEDICINE (2007)
Aetiology in adult patients with bronchiectasis
A. Shoemark et al.
RESPIRATORY MEDICINE (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Proton MRI appearance of cystic fibrosis: Comparison to CT
Michael Puderbach et al.
EUROPEAN RADIOLOGY (2007)
Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
Paul King
DRUGS (2007)
Characterisation of the onset and presenting clinical features of adult bronchiectasis
Paul T. King et al.
RESPIRATORY MEDICINE (2006)
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
Diana Bilton et al.
CHEST (2006)
The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
G. Davies et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Inhaled steroids improve quality of life in patients with steady-state bronchiectasis
Miguel A. Martinez-Garcia et al.
RESPIRATORY MEDICINE (2006)
Nonpharmacologic airway clearance therapies - ACCP evidence-based clinical practice guidelines
FD McCool et al.
CHEST (2006)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms
RJ Gillis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms
KK Jefferson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis
P Scheinberg et al.
CHEST (2005)
Inhaled fluticasone in bronchiectasis: a 12 month study
KW Tsang et al.
THORAX (2005)
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa
ME Drobnic et al.
ANNALS OF PHARMACOTHERAPY (2005)
Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward
MG Hughes et al.
CRITICAL CARE MEDICINE (2004)
Strategy of antibiotic rotation: Long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia
D Gruson et al.
CRITICAL CARE MEDICINE (2003)
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia
I Horvath et al.
THORAX (2003)
Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction
E Daviskas et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2002)
Biofilms: Survival mechanisms of clinically relevant microorganisms
RM Donlan et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
CT of airways disease and bronchiectasis
G McGuinness et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2002)
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis
MJ Montgomery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Thoracoscopic lobectomy for benign disease - a single centre study on 64 cases
A Weber et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2001)
Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis
NR Henig et al.
THORAX (2001)
An investigation into causative factors in patients with bronchiectasis
MC Pasteur et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis
AF Barker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
